Cancer Cause And Prevention Research federal funding in FY2025

The Cancer Cause/Prevention Research × FY2025 join

A CFDA × fiscal-year page exists because two tables meet. $695,772,340.50 is the meeting point for Cancer Cause And Prevention Research and FY2025. It does not mean FY2025 specialized in this program because of a published causal story. It does not mean FEC donations funded these awards. Different datasets, even when calendars overlap. Campus names, principal investigators, and study titles are unpublished on this packet.

Read /programs/93.393/ (CFDA 93.393) for the program rollup, /fiscal-years/2025/ (FY2025 federal spending) for the year rollup, /programs/ (All programs) for every CFDA hub, and /ties/ (All spending ties) for the rest of the join list. Do not add those pages into $695,772,340.50. Recipients are unpublished. Four hundred sixty-two FY2025 award records is a moderate research file, not 462 unique campuses. Continuations add rows without naming a new lab.

Cancer Cause And Prevention Research without a year filter is a different page

USAspending labels CFDA 93.393 as Cancer Cause And Prevention Research. That code produced $695,772,340.50 when crossed with fiscal year 2025. The program-wide hub does not require a FY2025 filter. The year hub does not require this CFDA. Only this tie applies both filters. The catalog title is CANCER CAUSE AND PREVENTION RESEARCH. Etiology versus prevention versus other research lines are not split inside this year cell. FY2025 figures can still move in later USAspending ingests.

The program extract-wide obligation total is $5,915,477,684.62 across 2,497 award records. FY2025 is 11.8% of that book. Other fiscal-year rows for CFDA 93.393 are separate cells. Do not fold /programs/ into this join as if every CFDA were this one. Keep 93.393.

FY2025 as the cancer cause-and-prevention yearlyTrend cell

FY2025 on USAspending.gov is a federal fiscal year, not a calendar year and not a state fiscal year. $695,772,340.50 is the Cancer Cause And Prevention Research slice of that year in this extract, not the government-wide FY2025 total. FY2025 figures can still move in later USAspending ingests. Prefer /fiscal-years/2025/ if the live year table moved. Outlays are unpublished.

462 FY2025 awards are not 462 cancer studies

462 is the FY2025 award-record count published on this pair. 2,497 is the program-extract award-record count across years. Dividing $695,772,340.50 by 2,497 would mix a one-year dollar total with a multi-year row count, so this page does not publish that ratio as a typical award. Unique recipients are unpublished. Four hundred sixty-two FY2025 award records is a moderate research file, not 462 unique campuses. Continuations add rows without naming a new lab.

Campus rankings this cancer-research join cannot support

Budget justifications, program evaluation reports, and press releases answer other questions. They are not the source of this cell. If a chart mixes cancer-biology research, a treatment-research twin, or a named-grantee list with CFDA 93.393 in FY2025, the chart has left this join. Campus names, principal investigators, and study titles are unpublished on this packet.

Cite USAspending.gov: Cancer Cause And Prevention Research (CFDA 93.393) obligated $695,772,340.50 in FY2025. Name Cancer Cause And Prevention Research and FY2025 together. Keep the obligation word. If /programs/93.393/ or /fiscal-years/2025/ has refreshed, prefer the live hub over this snapshot for current rows. The pair is not an investigator directory, a protocol catalog, or an outlay register. 11.8% of $5,915,477,684.62 is the program share on this packet, not a budget score.

What this 93.393 × FY2025 snapshot is not

Open /programs/93.393/ for CFDA 93.393, /fiscal-years/2025/ for FY2025 federal spending, /programs/ (All programs) for other catalog lines, and /ties/ (All spending ties) for other pairs. None of those links convert this cell into cancer-biology research, a treatment-research twin, or a named-grantee list, into outlays this packet omits, or into a contractor list. Cite both sides: Cancer Cause And Prevention Research and FY2025, $695,772,340.50, USAspending.gov, obligations only.

Questions

How much did Cancer Cause And Prevention Research show in federal obligations in FY2025?

USAspending.gov records $695,772,340.50 in Cancer Cause And Prevention Research obligations for FY2025 (CFDA 93.393) across 462 awards. That is an obligation aggregate for the pair, not an outlay and not the program-wide $5,915,477,684.62.

Is Cancer Cause and Prevention Research FY2025 cash already paid?

No. $695,772,340.50 is a yearlyTrend obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for Cancer Cause And Prevention Research in FY2025. Original filings remain on USAspending.gov.

Do 462 awards mean 462 cancer studies?

No. 462 is the FY2025 award-record count on this pair, not a published unique-recipient census. The program extract lists 2,497 awards across years. Modifications can add rows. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.

Which pages parent Cancer Cause And Prevention Research and FY2025?

The CFDA 93.393 hub is the program parent. The FY2025 federal-spending hub is the year parent. All programs lists CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Cancer Cause And Prevention Research × FY2025 at $695,772,340.50.